# Study Evaluating Enbrel in Patients With Rheumatoid Arthritis

> **NCT00245934** · — · COMPLETED · sponsor: **Wyeth is now a wholly owned subsidiary of Pfizer** · enrollment: 1500 (—)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Enbrel

## Key facts

- **NCT ID:** NCT00245934
- **Lead sponsor:** Wyeth is now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** —
- **Final completion:** 2005-07
- **Target enrollment:** 1500 (—)
- **Last updated:** 2007-12-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00245934

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00245934, "Study Evaluating Enbrel in Patients With Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00245934. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*